Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added a government operating status notice and reference to NIH Clinical Center operations, plus a link to official status updates. - Bumped version from v3.1.0 to v3.2.0; prior v3.1.0 deletion indicates the version refresh.SummaryDifference3%
- Check18 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed drug information for Pembrolizumab, Paclitaxel, and Carboplatin, while removing various terms related to esophageal cancer and other neoplasms.SummaryDifference4%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.